Hospitals | April 14, 2026
Shalby Hospitals gets 5-year kidney transplant approval for Ahmedabad Krishna Unit
The license is valid for five years, effective from April 9, 2026
The license is valid for five years, effective from April 9, 2026
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems
These surgeries involve no bone cuts, minimal surgical trauma, smaller incisions and significantly reduced blood loss
The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation
Each program will rely on partnerships between Novartis teams and local networks—including health authorities, community organizations and private sector groups
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
The company says the platform offers improved manufacturability and functional advantages
The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
Subscribe To Our Newsletter & Stay Updated
